About 5 results found for searched term "JNK2-IN-1" (0.115 seconds)
Cat.No. | Name | Target |
---|---|---|
M42127 | JNK2-IN-1 | JNK |
JNK2-IN-1 is a JNK2 inhibitor (Kds: 79.2 μM). | ||
M9388 | Tanzisertib | JNK |
CC-930 | ||
Tanzisertib (CC-930) is a potent JNK1/2/3 inhibitor with IC50s of 61/7/6 nM, respectively. | ||
M10633 | AS601245 | JNK |
AS-601245 | ||
AS601245 is an orally active, selective, ATP competitive JNK (c-Jun NH2-terminal protein kinase) inhibitor with IC50 values of 150, 220, and 70 nM for JNK human isoforms (hJNK1, hJNK2, and hJNK3), respectively. | ||
M42123 | JNK-IN-12 | JNK |
JNK-IN-12 is a mitochondrial-targeted JNK inhibitor (IC50=66.3 nM), consisting of a mitochondrial-specific cell-penetrating peptide and a specific inhibitor of JNK, SP600125. | ||
M55643 | SKLB-163 | Apoptosis |
SKLB163 | ||
SKLB-163 is an orally active inhibitor for Rho GDP-dissociation (RhoGDI). SKLB-163 acts by downregulating RhoGDI, activating JNK-1 signaling pathway and caspase-3, and reducing phosphorylated Akt and p44/42 MAPK. SKLB-163 inhibits highly expressed RhoGDI tumor cell proliferation and migration, and increases radiosensitivity of tumor cells. SKLB-163 induces cancer cell Apoptosis. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.